Researchers found that the Mead Johnson formula group had fewer episodes, with a shorter average duration, of acute respiratory infections compared to control.
A Mead Johnson milk-based product containing omega-3 fatty acid DHA, a prebiotic blend of polydextrose (PDX) and galactooligosaccharides (GOS), and a yeast beta-glucan reduced incidence of acute respiratory infections in children. Mead Johnson presented the results of its study at the recent Experimental Biology conference in Boston.
The double-blind, randomized, controlled trial took place over 28 weeks. Subjects were 310 healthy children aged 3-4 years, who were administered three servings/day of the Mead Johnson milk-based formula. The formula contained 25 mg/serving DHA, 1.2 g/serving PDX and GOS, and 12.8 mg/serving of yeast Wellmune beta-glucans from supplier Biothera (Eagan, MN). The control group received powdered cow’s milk.
Researchers found that the Mead Johnson formula group had fewer episodes, with a shorter average duration, of acute respiratory infections compared to control.
GC Rieber VivoMega uses AI platform from Intelecy to boost efficiency, quality, and sustainability
August 26th 2024According to the company’s announcement, the AI platform is able to identify real-time deviations or anomalies in GC Rieber VivoMega’s processing facilities and report them via a cloud-based, comprehensive, centralized system.